December 13, 2018
Obesity, Cancer Development, and Immunotherapy Response
How does obesity impact cancer development and immunotherapy response? Find out in our review of cutting-edge combined oncology and metabolic disease studies.
LEARN MORE
December 11, 2018
Preclinical Applications for Non-Invasive Imaging Technologies
In this introduction to preclinical imaging, we explore optical imaging technologies, such as bioluminescent and ...
LEARN MORE
December 6, 2018
Exercise, Liver Cancer, and NAFLD Mortality
Our current understanding of the mechanisms linking obesity and liver cancer is poor. Preclinical research links ...
LEARN MORE
December 4, 2018
Preclinical Immunotherapy Safety and Toxicity Assessment
While the overall objectives for preclinical evaluation of cancer immunotherapies are identical to other anticancer ...
LEARN MORE
November 29, 2018
Where Do Organoids Fit in Preclinical Cancer Modeling?
There’s a wide range of new preclinical cancer models being developed, each with their own strengths and best uses. ...
LEARN MORE
November 27, 2018
Advances in Type 1 Diabetes Research and Treatment
Review the latest cutting-edge advances in type 1 diabetes including an oral anti-diabetes agent, the artificial ...
LEARN MORE
November 22, 2018
Are Cancer Stem Cells a Prime Target for Therapy?
Cancer stem cells (CSC) represent one of the most challenging targets for cancer therapy today. Here we review the background to this phenomenon and explore the various experimental models that are used to investigate anticancer therapies targeting CSCs.
LEARN MORE
November 20, 2018
Bioelectronic Medicine and Autoimmune Diseases
Is bioelectronic medicine the future of treatment for autoimmune diseases like lupus, rheumatoid arthritis, and Crohn’s ...
LEARN MORE
November 15, 2018
Prostate Cancer PDX Models and Oncology Analysis Studies: ENA 2018
This week at ENA 2018, we’re presenting up to date research on our PDX models, including our newly developed prostate ...
LEARN MORE
November 15, 2018
Murine Immuno-Oncology Models: ENA 2018
At ENA 2018 we’re presenting new data on our wide range of immuno-oncology (I/O) platforms, with four posters covering ...
LEARN MORE
November 14, 2018
Humanized Immuno-Oncology Model Update: ENA 2018
This week, at ENA Dublin 2018, we’re presenting new data from our novel humanized in vivo preclinical platforms. This blog recaps all the new data on double knock-in humanized drug target models and our PBMC-humanized system.
LEARN MORE
October 24, 2018
PDX Study Investigates Cetuximab for Esophageal Cancer
Esophageal cancer patients lack targeted agent treatment options, leaving them with a poor prognosis ...
LEARN MORE
October 16, 2018
Humanized Mouse Models for Immunotherapy Research
Humanized mouse models simulate real patient responses for the evaluation of immunotherapeutic drug candidates. This ...
LEARN MORE
October 11, 2018
Tumor Homograft Model Generation: Dissociated Tumor Cells vs Tumor Fragments
Novel murine immunocompetent models are needed to overcome issues with commonly used syngeneic tumor models and ...
LEARN MORE
October 9, 2018
Why PDX Are Needed for Metastatic Breast Cancer Research
Metastatic breast cancer is currently incurable, though preclinical research is ongoing. Generating new therapies for ...
LEARN MORE
